|Title:||Intellectual Property Management in WA Health|
|Document ID:||Information Circular IC 0178/14|
|Date of issue:||Thursday, 6 February 2014|
|Status:||NO LONGER APPLICABLE|
|Description:||The Circular informs WA Health staff of the State governmentís intellectual property (IP) policy and specific IP management and reporting procedures in WA Health.|
|Period of effect:||from 1 February 2014 to 31 December 2015|
|Review date:||31 December 2015|
|Authorised by:||Professor Gary Geelhoed, Chief Medical Officer, Office of the Chief Medical Officer, 04-Feb-2014|
|Print version:||View print version|
Intellectual Property Management in WA Health
The WA Government Intellectual Property Policy and Best Practice Guidelines provides a policy framework for the protection, management and commercialisation of Intellectual Property (IP) generated with State Government resources. The policy recognises that IP created within Government agencies is a major potential source of value to the Western Australian economy and community. The Government's aim is to actively seek to optimise the economic, social and environmental benefits to Western Australians from the use and commercialisation of IP, in conjunction with the business community.
In accordance with the policy, Government agencies should ensure that:
The Department of Health strongly supports this approach to the management of health sector IP, recognising the great value that innovation and commercialisation can have in both advancing health care delivery and optimising the return on the State Government's investment in health.
Protection of WA Health IP
IP is the tangible representation of intellect and creativity. There is wide diversity in the type of IP that is being generated in WA Health. The rights to IP generated in the course of normal working activities, or logical extensions of these (this can include activities undertaken offsite and/or after hours) are generally vested in the employer.
The OD 0383/12 WA Health Code of Conduct states: “(Staff will) Protect and responsibly manage the intellectual property developed in, or used by, WA Health. The intellectual property we create in the course of our employment may remain the property of WA Health”.
IP usually arises as a consequence of the core activities of the sector and, if value is to be added, some form of protection generally must be invoked if the IP is considered to have strategic or commercial potential. The level of protection will depend upon the intrinsic value of the IP and its commercialisation potential. The costs of protection must be considered in the light of an assessment of this value.
The most usual forms of protection that are to be used in WA Health are:
Copyright: protects the original expression of ideas (not the ideas themselves). This includes written works, internet and multimedia presentations, computer software, business management systems, etc. Copyright is automatic, whether explicitly claimed or not (ie does not require formal registration), and is free of charge.
A copyright disclaimer should be added to all publications produced by WA Health, whether in printed or electronic form. The copyright disclaimer should use the following wording:
”Copyright to this material is vested in the State of Western Australia unless otherwise indicated. Apart from any fair dealing for the purposes of private study, research, criticism or review, as permitted under the provisions of the Copyright Act 1968, no part may be reproduced or re-used for any purposes whatsoever without written permission of the State of Western Australia”.
Patents: provide time-limited monopolies over commercial exploitation of inventions or innovations that have acceptable degrees of novelty, usefulness and appropriateness. These require strict formal registration procedures, and incur costs that can be quite high and often outside the core funding activities of government agencies. Particular care must be taken with respect to prior use or public disclosure of the invention or innovation, and in some circumstances, the establishment of "first to invent" status. This is a highly sensitive and complex area, and specialist advice should be sought, and appropriate procedures instituted, before a potentially inventive project is initiated.
Publishing rights: researchers should be allowed to freely disseminate the results of their work. This will not, however, apply if the research outcomes have confidentiality restrictions, are patentable or may have commercialisation potential.
Trademark: something that is used to distinguish goods and services of one trader from those of another. It is registrable, and has associated costs.
Design: protects the appearance of products. Is registrable and has associated costs.
Trade secret: proprietary knowledge (know-how) and other confidential information. Non-registrable, no direct cost, but is of limited application in the public domain.
It should be emphasised that even when commercialisation of IP is not contemplated, the enforcement of IP rights may be necessary to discourage potentially inappropriate use of the material by other parties.
State Government Rewards Policy
The incentives for employees aspect of the policy is given further consideration in the document Encouraging Innovation by Government employees: Procedures for the payment of monetary rewards to innovative Government employees.
IP Management in WA Health
The Department of Health has established an intellectual property management strategy for WA Health that aligns with the third pillar of the Strategic Intent for WA Health: Making the best use of funds and resources.
The first point of contact for any IP issues would be the research administration office or equivalent at your site of work. When necessary the Research Development Unit (RDU), Office of the Chief Medical Officer, should be the next point of contact for the protection and commercialisation of IP in WA Health.
The RDU can assist IP developers and managers in the following ways:
Medical Research Commercialisation Fund (MRCF)
The Department of Health is able to offer WA Health researchers the opportunity to apply for MRCF funding for early stage development and commercialisation of intellectual property.
The MRCF is a pre-seed investment fund which aims to address the existing funding gap between the development and commercialisation of biomedical research. In addition to development funds the fund managers are able to provide professional commercialisation advice, including patent and project management support.
For information on IP management in WA Health contact the Research Development Unit, Department of Health
Email: Neil Lynch, Senior Policy Officer RDU
Professor Gary Geelhoed
This circular last updated: Thursday, 6 February 2014 at 12:06pm